Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Multiple sclerosis; This serious case was reported by a consumer via interactive digital media and described the occurrence of multiple sclerosis in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced multiple sclerosis (Verbatim: Multiple sclerosis) (serious criteria GSK medically significant). The outcome of the multiple sclerosis was not reported. It was unknown if the reporter considered the multiple sclerosis to be related to Shingles vaccine. The company considered the multiple sclerosis to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 22-MAR-2025 This case was reported by a patient via interactive digital media. The patient got Multiple sclerosis right after they gave a shingle vaccine.; Sender's Comments: Multiple sclerosis is an unlisted event which is considered unrelated to GSK vaccine Shingles vaccine